Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2010
04/15/2010WO2010042030A1 Aspartyl protease inhibitors
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010WO2010002209A3 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
04/15/2010US20100093816 [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-ylmethyl]-dimethyl-ammonium napadisylate for treating chronic obstructive pulmonary disease
04/15/2010US20100093788 Heterocyclic benzimidazoles as trpm8 modulators
04/15/2010US20100093743 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
04/15/2010US20100093707 Acid amide derivatives, process for their production and pesticides containing them
04/14/2010EP2174936A1 PNA monomer and precursor
04/14/2010EP2174935A1 Linezolid Compositions
04/14/2010EP2173728A2 Heterocyclic modulators of pkb
04/14/2010EP2173727A1 Novel herbicides
04/14/2010EP2173726A2 Process for preparing oxazolidine- and oxazolidinone-aminodiols
04/14/2010EP1400515B1 Cyclic diamine compound having five-membered cyclic group
04/13/2010US7696379 Acetylene derivatives
04/13/2010US7696205 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide
04/13/2010US7696129 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
04/13/2010CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors
04/13/2010CA2422703C Process for the preparation of mesylates of piperazine derivatives
04/08/2010WO2010039238A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039186A2 Compounds useful as faah modulators and uses thereof
04/08/2010US20100087654 Pseudoproline dipeptides
04/08/2010US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2010CA2739303A1 Compounds for inflammation and immune-related uses
04/07/2010EP2170849A1 Oxazole tyrosine kinase inhibitors
04/07/2010EP2170830A1 Compounds and methods for kinase modulation, and indications therefor
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/06/2010US7691889 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide
04/06/2010CA2464846C Dibenzylamine compounds and pharmaceutical use thereof
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010036908A1 Use of benzoxazole compounds in the treatment of malaria
04/01/2010WO2010036905A1 Benzoxazole compounds and methods of use
04/01/2010WO2010034562A1 Method for producing phenylene bis-oxazolines
04/01/2010WO2010034236A1 Process for the manufacture of n-acylbiphenyl alanine
04/01/2010WO2009154785A3 C4-substituted alpha-keto oxazoles
04/01/2010DE102008049431A1 New oxazol-5-yl-ethanone derivative, useful as building blocks for the synthesis of complex compounds e.g. drugs and pesticides e.g. phorboxazole A and is also useful for producing optical materials
03/2010
03/31/2010EP1904465B1 Method of synthesis of imidazole-amino acid derivatives and related compounds
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010CN101687813A 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
03/31/2010CN101687787A Inhibitors of iap
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
03/30/2010CA2572508C One pot synthesis of 2-oxazolidinone derivatives
03/30/2010CA2405971C New piperazine and piperidine compounds
03/25/2010WO2010031835A2 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/25/2010WO2010031769A1 Process for the preparation of an oxazolidinone antibacterial agent and intermediates thereof
03/25/2010WO2010009405A9 Targeted nitroxide agents
03/25/2010US20100076029 Compounds Which Selectively Modulate The CB2 Receptor
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010CA2737099A1 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/24/2010EP2166006A1 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/24/2010EP2166005A1 Method for making phenylenebisoxazolines
03/24/2010CN101679323A Treatment of duchenne muscular dystrophy
03/24/2010CN101679322A Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
03/24/2010CN101679267A Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN100595266C Photo-labile pro-fragrance conjugates
03/23/2010US7683215 Optically active bisoxazoline compounds, process for production of the same and use thereof
03/23/2010US7683182 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010CA2395603C Linezolid-crystal form ii
03/18/2010WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods
03/18/2010WO2010029379A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
03/18/2010WO2010008522A3 Nucleophilic fluorination of aromatic compounds
03/18/2010US20100069643 Convergent Process for the Synthesis of Taxane Derivatives
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/17/2010EP2163547A1 Process for the preparation of an oxazolidinone antibacterial agent and intermediates thereof
03/17/2010EP2162439A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
03/17/2010EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors
03/17/2010CN101671313A Beta-naphthyl methyl substituted spiral bisoxazoline ligand, synthetic method and application thereof
03/17/2010CN101671312A Chiral oxazolines derivative and synthesis method thereof
03/16/2010US7678915 Process for production of piperidine derivatives
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010US20100063298 11c-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent
03/11/2010US20100060155 Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same
03/11/2010US20100060154 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative
03/10/2010EP1556385B1 Heterocyclocarboxamide derivatives
03/10/2010CN101665469A Heterocyclic compounds useful as Nurrl activators
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/04/2010WO2010025179A1 1-(4-ureidobenzoyl)piperazine derivatives
03/04/2010WO2010023892A1 N-carboxy amino acid anhydride and amino acid carbamate compound production method
03/04/2010WO2009015111A8 Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates
03/04/2010US20100056786 Method for Producing Alkylanilides from Halobenzene Derivatives
03/04/2010US20100056503 Compounds for modulating integrin CD11b/CD18
03/04/2010CA2733661A1 1-(4-ureidobenzoyl)piperazine derivatives
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use
03/03/2010EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/02/2010US7671213 4-Naphthyl-substituted, e.g., 2,2-bis[2-[(4S)-(1-naphthyl)-5,5-dimethyloxazoline]]propane; catalyst for preparing cyclopropanecarboxylates from prochiral olefins; amidating a 1-amino-1-naphthyl-2-(cyclo)alkanol with a dicarboxylate or diacyl halide and cyclizing the diamide formed with a Lewis acid
03/02/2010US7671117 Resin composition
03/02/2010US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors
03/02/2010US7670205 Crotch-possessing corrective garment
02/2010
02/25/2010WO2010021693A2 Mif modulators
02/25/2010WO2010020352A1 Compounds having electron transport properties, their preparation and use
02/25/2010WO2009132740A3 Reactive ionic liquids
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 210